Key result
SARS-CoV-2 infection linked to widespread mitochondrial vacuolations and myofilament degradation in Long COVID cardiomyocytes.
Why the study?
Vigilance for Long COVID-related cardiovascular issues remains essential, but their specific pathophysiology is largely unexplored.
Does SARS-CoV-2 infection cause persistent mitochondrial damage and myofilament degradation in cardiomyocytes of patients with Long COVID?
Observational (n=5)
No
Does SARS-CoV-2 infection cause persistent mitochondrial damage and myofilament degradation in cardiomyocytes of patients with Long COVID?
SARS-CoV-2 infection is associated with profound and persistent mitochondrial damage and myofilament degradation in cardiomyocytes, providing a potential cellular mechanism for Long COVID cardiovascular manifestations.
Hypothesis-generating for mitochondrial-targeted therapies in Long COVID myocarditis; leaves open causal role and should not change practice.
• Our investigation provides histopathological and electron microscopic analyses from endomyocardial biopsies of five patients who experienced various post-COVID-19 cardiovascular outcomes. • Electron microscopy revealed widespread mitochondrial disorder and the presence of myofilament degradation within the cardiomyocytes from the patients. • Similar mitochondria disorganization were found in SARS-CoV-2 infected mice. • Proteomic profiling of SARS-CoV-2 infected mouse heart tissues indicated that the most significantly changed genes and proteins were related to mitochondrial structure and function. With the COVID-19 pandemic becoming endemic, vigilance for Long COVID-related cardiovascular issues remains essential, though their specific pathophysiology is largely unexplored. Our study investigates the persistent cardiovascular symptoms observed in individuals long after contracting SARS-CoV-2, a condition commonly referred to as “Long COVID”, which has significantly affected millions globally. We meticulously describe the cardiovascular outcomes in five patients, encompassing a range of severe conditions such as sudden cardiac death during exercise, coronary atherosclerotic heart disease, acute inferior myocardial infarction, and acute myocarditis. All five patients were diagnosed with myocarditis, confirmed through endomyocardial biopsy and histochemical staining, which identified inflammatory cell infiltration in their heart tissue. Crucially, electron microscopy revealed widespread mitochondrial vacuolations and the presence of myofilament degradation within the cardiomyocytes of these patients. These findings were mirrored in SARS-CoV-2-infected mice, suggesting a potential underlying cellular mechanism for the cardiac effects associated with Long COVID. Our findings demonstrate a profound impact of SARS-CoV-2 on mitochondrial integrity, shedding light on the cardiovascular implications of Long COVID.
No takes yet. Share an insight, caveat, or question.
Che et al. (2025) conducted an observational in Long COVID-associated cardiovascular manifestations (n=5). SARS-CoV-2 infection vs. Uninfected controls (in mouse model) was evaluated on Mitochondrial ultrastructural disorder in cardiomyocytes. SARS-CoV-2 infection was associated with widespread mitochondrial vacuolations and myofilament degradation in the cardiomyocytes of patients with Long COVID cardiovascular symptoms.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: